glp 1 liraglutide PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: Teva Pharmaceuticals Launches Liraglutide Injection

Facility implications of aqueous-based peptide synthesis: By eliminating reliance on corrosive solvents and reducing overall unit operations involved in peptide manufacturing, this approach could significantly reduce the facility burden associated with GLP-1 manufacturing

The caveat to this is that we need more specialists in obesity medicine in this country to be able to use these medications the way theyre supposed to be used

68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5

By releasing microRNA-18b, which inhibits trophoblasts production of Notch2, HUC-MSCs-EXOs stimulated trophoblast motility

Chitosan- or PEI-coated nanoformulations leverage protonated amines to interact electrostatically with sialic acid-rich mucins, improving mucosal adhesion, residence time, and paracellular opening, thereby enhancing transport along the olfactory and trigeminal pathways (121, 122)